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Objectives: Vein graft surveillance iswidely acknowledged to be of benefit in improving raft patency at least in the first 
year after arterial bypass urgery. The aim of this study was to examine the effect of a surveillance programme on the 
patency of synthetic infrainguinal bypass grafts. 
Design: A prospective study of 69 consecutive prosthetic bypass grafts was undertaken over a 3 year period. 
Methods: Patients were seen at 3 monthly intervals after surgery and underwent measurement of ankle brachiaI pressure 
indkes and a colour Duplex scan of the graft. 
Results; The surveillance programme was able to detect reatable lesions in five grafts and in the run-off vessels of two 
other grafts prior to occlusion. Hozoever 14 grafts failed after the first 30 days, 12 of which were not predicted by the 
surveillance programme. 
Conclusions; Surveillance appears to be of limited benefit in the maintenance ofpatency of synthetic infrainguinal bypass 
grafts. 
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Introduction 
Autologous aphenous vein is the conduit of choice 
for infrainguinal rterial bypass surgery. 1 When there 
is no ipsilateral long saphenous vein available, alter- 
native vein such as the short saphenous vein, the 
contralateral long saphenous vein or arm vein all give 
acceptable patency rates. 2-4 It is only when these 
sources of vein are exhausted that many surgeons turn 
to the use of prosthetic alternatives such as polytetra- 
fluoroethylene (PTFE), polyurethane, dacron, bovine 
vein or human umbilical vein. The reported patency 
rates for synthetic materials vary considerably with 
figures of 40-90% being quoted at i year, 5-9 whilst at 5 
years the values range from 18-60% .1,5-9 Even the best 
reported patency rates for prosthetic grafts do not 
match those of vein grafts. The most common reasons 
for failure of synthetic grafts are progression of 
atherosclerotic disease 7'1°-13 and anastomotic ntimal 
hyperplasia. 14 This contrasts with vein grafts where 
intrinsic stenoses due to intimal hyperplasia represent 
the commonest cause of graft failure between I month 
and 1 year after surgery. 15-18 Few centres enter 
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prosthetic grafts into surveillance programmes as the 
benefits of a surveillance programme for synthetic 
grafts have yet to be proven whilst surveillance for 
vein grafts is widely accepted to improve graft 
patency. 
In order to assess the efficacy of synthetic graft 
surveillance, all prosthetic infrainguinal bypass grafts 
performed at the Leicester Royal Infirmary from 
January 1992 onwards were prospectively entered into 
a surveillance programme. Patients were seen post- 
operatively at 1 month then at 3 monthly intervals. 
The surveillance consisted of a clinical history, meas- 
urement of resting ankle brachial pressure index 
(ABPI), and a colour Duplex scan of the graft inflow, 
outflow and anastomoses. This paper describes the 
results of the programme. 
Patients and Methods 
All patients undergoing an infrainguinal bypass pro- 
cedure between January 1st 1992 and December 31st 
1994 using prosthetic material were prospectively 
entered into a surveillance programme. Surveillance 
of these grafts took place at one month then at 3 month 
intervals after the initial operation, providing the graft 
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was still patent. The results described include those 
grafts which failed before they could attend the 
surveillance clinic. 
All patients attending the surveillance clinic had a 
colour-coded Duplex scan (Diasonics Spectra, Dia- 
sonics Sonotron, Bedford, U.K.) of the graft inflow, 
outflow and the proximal and distal anastomoses. 
This took place in our Vascular Studies Unit where the 
patient was seen at each visit by an experienced 
technician. A peak systolic velocity ratio of > 2.0 at the 
anastomosis was taken to represent a significant 
anastomotic stenosis. A segmental peak velocity ratio 
> 2.0 in the native inflow or run-off vessel was taken 
as representing a significant native vessel stenosis. 
Initial treatment of anastomotic or native artery 
stenoses was by Percutaneous Transluminal Angio- 
plasty (PTA). 
Data analysis 
Graft patency was assessed using the recommenda- 
tions of Rutherford 19 based on the suggestions of the 
Ad Hoc Committee on Reporting Standards of the 
Society for Vascular Surgery. 2° Primary patency was 
defined as uninterrupted patency after the initial 
surgery with no further procedure performed on the 
graft. Primary assisted patency requires that the graft 
remains patent but procedures uch as PTA can be 
performed to prevent subsequent graft failure. Secon- 
dary patency allows procedures such as thrombolysis 
or thrombectomy to be performed to salvage an 
occluded graft. Patients who died during follow up 
were censored to their last clinic attendance. Statistical 
analysis was performed using the statistical package 
SPSS for Windows (SPSS, Chertsey, U.K.). 
Results 
There were a total of 69 synthetic grafts in 65 patients. 
The median (range) patient age was 69 (48-92) years. 
Forty-five of these patients were male and 20 were 
female. Twenty (29 %) of the patients admitted to being 
smokers at the time of their operation, 18 (26%) were 
diabetic and 28 (41%) were hypertensive. Nineteen of 
the operations were performed for intermittent claudi- 
cation, 42 for chronic critical imb ischaemia nd eight 
for acute lower limb ischaemia. 
In total, 49 above-knee popliteal, six below-knee 
popliteal, 12 femorodistal nd two iliopopliteal grafts 
were performed using either PTFE (56 grafts), polyu- 
Table 1. Graft details 
Material used 
PTFE Corvita Procol Miller collar 
Iliopopliteal 2 0 0 0 
Above-knee popliteal 38 9 2 16 
Below-knee popliteat 6 0 0 3 
Femorodistal 10 1 1 11 
rethane ("Corvita") (10 grafts) or tanned bovine vein 
("Procol') (3 grafts). The type of graft used at each 
position is shown in Table 1. A "Miller collar "21 of vein 
was used at the distal anastomosis n 30 (44%) cases. 
The median (range) follow up was 9 (1-34) months. 
Sixteen grafts failed within the first 30 days post- 
operatively giving a 1 month patency rate of 77%. 
Seven patients died perioperatively producing a peri- 
operative mortality rate of 10%. Six of these deaths 
were in patients having surgery for limb-threatening 
chronic critical ischaemia, the other patient had 
surgery for an acutely ischaemic limb. Five of the 
patients who died in the perioperative period did so 
after their grafts failed. Fifty-one patients remained 
alive with a functioning raft to enter the surveillance 
programme at 1 month. 
After the initial 30 day period, 14 grafts subse- 
quently occluded, 12 in the interval between surveil- 
lance clinic attendances. The median (range) time to 
occlusion in these grafts was 6.5 (3-32) months. Five 
grafts were found to have a treatable lesion at the 
distal anastomosis by the surveillance programme at a 
median (range) interval of 6 (3-30) months after 
surgery. Two of these grafts occluded prior to PTA. A 
further two grafts had treatable lesions detected in the 
popliteal artery distal to the anastomosis which were 
successfully treated by PTA. 
The seven grafts with abnormal findings at surveil- 
lance are shown in Table 2. The primar3~ primary 
assisted and secondary patencies at 12 months were 
54%, 55% and 55%. At 24 months the figures were 
39%, 46% and 46%. The patency rates are demon- 
strated in the survival curve in Fig. 1. There is little 
difference between the primary assisted and secon- 
dary patency rates. 
Whilst there is a preponderance of 'corvita' grafts 
among those found to have treatable lesions, there was 
no significant difference between the graft materials in 
the number of unexpected graft occlusions (p = 0.44, 
Log Rank test). 
A Cox multivariate analysis 22 of the following risk 
factors; diabetes mellitus, hypertension, ischaemic 
heart disease, continued smoking (as admitted by the 
patient), the site of the distal anastomosis, the use of a 
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Table 2. Abnormalities detected by surveillance 
Patient Graft Details 
66yr Male Corvita, AK fempop 
78yr Female Corvita, AK fempop 
63yr Male Corvita, AK fempop 
79yr Male PTFE, AK fempop 
66yr Female Corvita, AK fempop 
65yr Female PTFE, AK fempop 
72yr Female Corvita, AK fempop 
2.5x velocity increase in distal popliteal artery at 22 months post-op. Had successful PTA. 
4x velocity increase in popliteal artery at 12 months post-op. Had successful PTA. 
3x velocity increase at distal anastomosis at5 months post-op. Graft occluded before angioplasty. 
2.5x velocity increase at distal anastomosis at6 months post-op. Graft occluded before angioplasty. 
2.5x velocity increase at distal anastomosis at3 months post-op. Had successful PTA. 
2.5x velocity increase at 29 months post-op. Had PTA of distal anastomosis and popliteal artery. 
3x velocity increase at distal anastomosis and 2x velocity increase inflow at 12 months post-op. 
Had successful PTA. 
Miller cuff, the material used and the indication for 
the operation showed no significant differences in 
occlusion or stenosis rates between the groups. How- 
ever, the numbers of grafts in each subgroup are small 
and it is difficult o draw any firm conclusions. 
Discussion 
Graft surveillance for vein grafts is of proven benefit 
4 17  18  23-32  in maintaining raft patency. ' • • However, the 
benefits from surveillance of PTFE grafts are not so 
clean The main causes of PTFE graft failure are 
progression ofatherosclerosis and anastomotic intimal 
hyperplasia nd any surveillance programme would 
have to detect and allow treatment of these problems 
before graft occlusion occurred. 33 As the results of 
treating a failed graft are worse than treating a failing 
graft, a surveillance programme would be of benefit in 
improving graft patency if it was cost effective and 
detected enough treatable l sions prior to graft occlu- 
sion. 34 Stenoses can be treated by open operation or by 
PTA. Inflow and run-oft disease can also be treated by 
PTA or by further arterial bypass urgery. If the graft 
has already occluded, then it may be treated by 
thrombolysis or thrombectomy prior to treating the 
underlying cause for the occlusion 1° but the results are 
not as good. 
There are few reports of surveillance programmes of
synthetic grafts in the literature. Sanchez et al. retro- 
spectively reviewed the results of their treatment of91 
'failing' PTFE grafts performed over a 12 year 
period. 34 These were grafts found to have a problem 
during routine follow up. They found 43 inflow and 83 
outflow lesions in addition to 10 lesions within the 
graft itself and eight anastomotic lesions. These grafts 
had all been followed up in an outpatient setting at 
1-2 monthly intervals for the first year, 3 monthly 
intervals for the second year and at 3-6 monthly 
intervals thereafter. Duplex scanning was available 
during the last 6 years of their study and 'most' 
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Fig. 1. Patency curves howing primar35 primary assisted and secondary patencies. The numbers at risk are shown at the bottom. A broken 
line is used where the standard error is greater than 10%. 
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patients were said to have had a Duplex scan during 
this time. However, the study is retrospective and the 
follow up protocol was not standardised. In addition, 
no mention is made of the number of unexpected graft 
failures during this time so we can not tell how 
successful their programme was at picking up prob- 
lems. They conclude that a surveillance programme 
may allow detection and treatment of graft-threat- 
ening lesions but that a prospective study is needed. 
Lalak et al. reported a prospective surveillance 
programme of 69 PTFE grafts over a 44 year period, s5 
Their report included only those patients who left 
hospital with a functioning graft and patients were 
seen at I month, 3 months then at 6 monthly intervals. 
There were no inflow or runoff problems found in this 
series but there were three proximal and one distal 
anastomotic stenoses requiring treatment. Twenty- 
seven grafts occluded during the 3 year follow up 
despite having been seen in the surveillance clinic 
during the preceding 6 months. They concluded that 
surveillance was of little benefit in improving overall 
synthetic graft patency. 
A prospective randomised study of graft surveil- 
lance by Lundell et al. 32 included 43 PTFE or compos- 
ite grafts. Twenty-three of these grafts were allocated 
to intensive surveillance with ABPI measurements 
and Duplex scans at 1 month, 3 months then 3 
monthly intervals. The remaining 23 grafts underwent 
'routine surveillance' at 1 month then 12 monthly 
intervals. These grafts had ABPI measurements but 
did not have a Duplex scan. Two of their PTFE grafts 
in the intensive surveillance group developed anasto- 
motic stenoses that were treated and one other PTFE 
graft with a stenosis occluded before it could be 
treated. Ten of their PTFE grafts and three of their 
composite grafts in the intensive surveillance group 
occluded without warning. There was no statistical 
difference between intensive and routine surveillance 
at 1 year but the numbers of PTFE grafts in the study 
were too small to make statistical comments beyond 
this time. 
Before deciding whether or not a screening pro- 
gramme is useful, we have to determine how effective 
the screening method is and how expensive the 
screening process is. In our study, we were able to 
detect haemodynamic abnormalities in five grafts and 
in two run-off vessels which we believed were 
indicative of threatening raft occlusion. Two of the 
grafts with anastomotic stenoses occluded before the 
patient returned to have a remedial procedure. Whilst 
surveillance was certainly useful in these seven 
patients, we also had 12 grafts fail unexpectedly 
during follow up. Haemodynamic abnormalities were 
not detected espite the patients being in our surveil- 
lance programme. Assuming the Duplex scanning was 
carried out effectivel3¢ and we believe it was, we can 
only conclude that surveillance at 3 monthly intervals 
is of limited use in improving the patency of synthetic 
infrainguinal bypass grafts. 
There are several possibilities why our grafts 
occluded between surveillance appointments and 
why we were unable to substantially alter our overall 
graft patency. Synthetic grafts are more thrombogenic 
than vein grafts and small haemodynamically insig- 
nificant stenoses causing minimal flow disturbance, 
which would not jeopardise vein graft patencN may 
lead to occlusion of synthetic grafts. AlternativelN the 
intimal hyperplasia t the anastomoses of synthetic 
grafts may progress more rapidly than that in vein 
grafts. Thus an insignificant stenosis een on duplex 
may advance to cause a graft occlusion within the 3 
month interval between surveillance appointments. 
The surveillance interval in Lalak's study was even 
longer - -  6 monthly after the first 3 months and there 
was a higher rate of unexpected graft occlusion. It 
would appear that the detection of treatable lesions in 
synthetic grafts before occlusion occurs is fraught with 
difficulties. A surveillance programme with a shorter 
interval between visits, perhaps monthly, may detect 
more treatable lesions but the costs of the programme 
would rise considerably We conclude that a prosthetic 
graft surveillance programme can not be justified. 
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